References
- ADEYEYE, C. M., and PRICE, J. C., 1991, Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics. Pharmaceutical Research, 8, 1377–1383.
- ADEYEYE, C. M., and PRICE, J. C., 1994, Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharmaceutical Research, 11, 575–579.
- ADEYEYE, C. M., and PRICE, J. C., 1997, Chemical, dissolution, stability and microscopic evaluation of suspensions of ibuprofen and sustained-release ibuprofen-wax microspheres. Journal of Microencapsulation, 14, 357–377.
- AKBUGA, J ., and BERGISADI, N., 1997, Effect of drug properties on physical and release characteristics of eudragit microspheres prepared by spherical crystallization technique. Drug Developments Industrial Pharmaceutics, 23, 407–411.
- BANAK AR, U. V., 1992, Pharmaceutical dissolution testing (New York: Marcel Dekker), pp. 192–193.
- BENrr A, S., Z OCTAL 0., and BENOIT, J. P., 1986,5-Fluorouracil: carnuba wax microspheres for chemoembolization: an in vitro evaluation. Journal of Pharmaceutical Science, 75, 847–851.
- CUSIMANO, A. G., and BECKER, C. H., 1968, Spray-congealed formulations of sulfaethylthiazole (SETD) and waxes for prolonged-release medication. Effect of wax. Journal of Pharmaceutical Science, 57, 1104–1111.
- DRAPER, E. B., and BECKER, C. H., 1966, Some wax formulations of sulfaethylthiazole produced by aqueous dispersion for prolonged-release medication. Journal of Pharmaceutical Science, 55, 376–380.
- GIANNOLA, L. I., DE CARO, V., and DI STEFANO, V., 1994, Comparative in-vitro evaluation of cumulative release of the urinary antiseptic nalidixic acid, pipemidic acid, cinoxacin and norfloxacin from white beeswax microspheres. Drug Developments in Industrial Pharmaceutics, 20, 2285–2297.
- GIANNOLA, L. I., DE Co, V., and SEVERINO, A., 1995, Carnuba wax microspheres loaded with valproic acid: preparation and evaluation of drug. Drug Developments in Industrial Pharmaceutics, 21, 1563–1572.
- GOODMAN GILMAN, A., RAU, T. W., Nms, A. S., and TAYLOR, P., 1991, The pharmacological basis of therapeutics (New York: Pergamon Press), pp. 233–234.
- GuPrA, R. G., and RAO, B. C., 1985, Microencapsulation of vitamin B12 by emulsion technique. Drug Developments Industrial Pharmaceutics, 11, 41–53.
- HMSO, 1993, British Pharmacopoeia (London, HMSO publication center), p. 554.
- HUSSAIN, H., FOSTER, T., HIRAI, S., KASHIHARA, T., BOTENHORST, R., and Jos, M., 1980, Nasal absorption of propranolol in humans. Journal of Pharmaceutical Science, 69, 1240–1244.
- IwAmmo, K., and WATANABE, J., 1985, Avoidance of first pass metabolism of propranolol after rectal administration as a function of the absorption site. Pharmaceutical Research, 1, 53–54.
- JANIKHEL, R. K., and ADEYEYE, C. M., 1997, Stereospecific formulation and characterization of sustained-release ibuprofen microspheres. Journal of Microencapsulation, 14, 409–426.
- KHAN, K. A., 1975, The concept of dissolution efficiency. Journal of Pharmaceutics and Pharmacology, 27, 48–49.
- LACHMAN, L., LIBERMAN, H. A., and KANIG, J. L., 1986, The theory and practice of industrial pharmacy (Philadelphia: Lea and Febiger), p. 67.
- MARIN BOSCA, M. T., OLLERO HINOJOSA, J., CONTREAS CLARAMONTE, M. D., and ISMAIL SALEM, I., 1996, Statistical comparison of two methods of dissolution of sustained-release theophylline tablets. Drug Developments in Industrial Pharmaceutics, 22, 595–601.
- MARTIN, A. SWARBRICK, J., and CAMMARATA, A., 1993, Physical Pharmacy (Philadelphia: Lea and Febiger), p. 426.
- MUNSON, P. L., MUELLER, R. A., and BREESE, G. R., 1994, Principles of pharmacology (New York: Chapman and Hall), pp. 139–140.
- Omso, T., and SHINTANI, M., 1990, Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. Journal of Pharmaceutical Science, 79, 1065–1071.
- PONGPAIBUL, Y., and WHITWORTH, C. W., 1986, Microencapsulation by emulsion non-solvent addition method. Drug Developments in Industrial Pharmaceutics, 12, 2387–2402.
- REYNOLDS, J. E. F. (ed.), 1996, The Extra Pharmacopeia (London: Royal Pharmaceutical Society), pp. 638–640.
- SHAND, D. G., Nimopms, E. M., and OATES, J. A., 1970, Plasma propranolol levels in adults with observation in four children. Clinical Pharmacology and therapeutics, 11, 112–118.
- TAYLAN, B., CAPAN, Y., GtivEN, 0., KEs, S., and HINCAL, A. A., 1996, Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets. Journal of Controlled Release, 38, 11–20.
- US PHARMACEUTICAL CONVENTION, 1995, United States Pharmaceopoeia (Rockville, MD: US Pharmaceutical Convention), pp. 1327–1329.